Skip to main content

Table 1 Patient demographics

From: Effect of intraoperative blood transfusion on Treg and FOXP3 in patients with digestive tract malignancies and different ABO blood types

  A B O AB F/χ2 P
Number of patients 20 20 20 20   
Age (yr) 53.45 ± 5.29 53.55 ± 5.9 54 ± 5.52 54.95 ± 6.68 0.272 0.845
Sex (n)      0.158 0.984
 Male 8 8 7 8   
 Female 12 12 13 12   
BMI (kg/m2) 21.48 ± 1.98 22.47 ± 1.38 21.79 ± 1.78 21.8 ± 1.7 1.178 0.324
Tumor type (n)      5.348 0.803
 Rectal cancer 3 2 3 3   
 Colon cancer 8 6 9 11   
 Gastric cancer 8 11 8 6   
 Esophageal cancer 1 1 0 0   
Treatment history (n)      0.213 0.975
 No 8 7 7 8   
 Chemoradiation 12 13 13 12   
Preoperative hemoglobin (g/L) 83.95 ± 8.42 84.45 ± 10.2 83.25 ± 8.74 83.55 ± 7.88 0.690 0.976
Operative time (min) 200 ± 30.96 213.7 ± 40.98 218.95 ± 25.9 226.55 ± 29.57 2.394 0.075
Operative technique (n)      0.595 0.898
 Laparotomy 8 6 8 7   
 Peritoneoscopy 12 14 12 13   
Blood transfusion volume (ml)
 RBC 425.0 ± 99.9 456.0 ± 113.1 440.0 ± 96.9 450.5 ± 113.3 0.331 0.803
 Plasma 474.5 ± 154.5 442.0 ± 140.1 506.0 ± 167.4 514.0 ± 165.9 0.872 0.460
  1. Data are expressed as number or mean ± standard deviation. A blood group A, B blood group B, AB blood group AB, O blood group O, BMI Body–mass index, RBC red blood cells, T0 before surgery, T1 immediately after transfusion, T2 1 day after transfusion, T3 5 days after transfusion